Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2012, Article ID 172104, 9 pages
http://dx.doi.org/10.1155/2012/172104
Clinical Study

Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials

1Wake Gastroenterology and Wake Research Associates, Raleigh, NC 27612, USA
2Luitpold Pharmaceuticals, Inc., Norristown, PA 19403, USA
3WebbWrites, LLC, Durham, NC 27705, USA
4Department of Pathology, Albert Einstein College of Medicine, NY 10461, USA

Received 11 April 2012; Accepted 23 June 2012

Academic Editor: Aurelio Maggio

Copyright © 2012 Charles F. Barish et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [29 citations]

The following is the list of published articles that have cited the current article.

  • Myles Wolf, Todd A Koch, and David B Bregman, “Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women,” Journal of Bone and Mineral Research, vol. 28, no. 8, pp. 1793–1803, 2013. View at Publisher · View at Google Scholar
  • Margaret Malone, Charles Barish, Andy He, and David Bregman, “Comparative Review of the Safety and Efficacy of Ferric Carboxymaltose Versus Standard Medical Care for the Treatment of Iron Deficiency Anemia in Bariatric and Gastric Surgery Patients,” Obesity Surgery, 2013. View at Publisher · View at Google Scholar
  • Veronika Markova, Astrid Nørgaard, Karsten Juhl Jørgensen, and Jens Langhoff-RoosCochrane Database of Systematic Reviews, 2013. View at Publisher · View at Google Scholar
  • Iftikhar Hussain, Jessica Bhoyroo, Angelia Butcher, Todd A. Koch, Andy He, and David B. Bregman, “Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia,” Anemia, vol. 2013, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  • Kurinchi Selvan Gurusamy, Myura Nagendran, Jack F Broadhurst, Stefan D Anker, and Toby RichardsCochrane Database of Systematic Reviews, 2014. View at Publisher · View at Google Scholar
  • Jesús Abelardo Barea Mendoza, Íñigo Gredilla Zubiría, Jesús González Olmedo, and Salvador Mateo Alvarez, “Hipofosfatemia. Reacción adversa poco conocida del hierro intravenoso,” Medicina Clínica, 2014. View at Publisher · View at Google Scholar
  • Dennis J. Cada, Terri L. Levien, and Danial E. Baker, “Ferric Carboxymaltose,” Hospital Pharmacy, vol. 49, no. 1, pp. 52–69, 2014. View at Publisher · View at Google Scholar
  • Lawrence T. Goodnough, and David B. Bregman, “Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia,” Therapeutic Advances in Hematology, vol. 5, no. 2, pp. 48–60, 2014. View at Publisher · View at Google Scholar
  • Renee A. Mischler, Seth M. Armah, Breanne N. Wright, Samer G. Mattar, Arthur D. Rosen, and Nana Gletsu-Miller, “Influence of diet and supplements on iron status after gastric bypass surgery,” Surgery for Obesity and Related Diseases, 2015. View at Publisher · View at Google Scholar
  • Veronika Markova, Astrid Norgaard, Karsten Juhl Jørgensen, and Jens Langhoff-RoosCochrane Database of Systematic Reviews, 2015. View at Publisher · View at Google Scholar
  • Maureen M. Okam, Todd A. Koch, and Minh- Ha Tran, “Iron deficiency anemia treatment response to oral iron therapy: A pooled analysis of five randomized controlled trials,” Haematologica, vol. 101, no. 1, pp. e6–e7, 2015. View at Publisher · View at Google Scholar
  • Rebeca Sánchez González, Hugo Guillermo Ternavasio-de la Vega, Leticia Moralejo Alonso, Sandra Inés Revuelta, and Aurelio Fuertes Martín, “Hipofosfatemia asociada a la administración intravenosa de hierro carboximaltosa en pacientes con anemia ferropénica. Un efecto secundario frecuente,” Medicina Clínica, 2015. View at Publisher · View at Google Scholar
  • Olus Api, Christian Breyman, Mustafa Çetiner, Cansun Demir, and Tevfik Ecder, “Diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period: Iron deficiency anemia working group consensus report,” Turk Jinekoloji ve Obstetrik Dernegi Dergisi, vol. 12, no. 3, pp. 173–181, 2015. View at Publisher · View at Google Scholar
  • Todd A. Koch, Jennifer Myers, and Lawrence Tim Goodnough, “Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations,” Anemia, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • William E. Strauss, Naomi V. Dahl, Zhu Li, Gloria Lau, and Lee F. Allen, “Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia,” BMC Hematology, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • Rebeca Sánchez González, Hugo Guillermo Ternavasio-de la Vega, Leticia Moralejo Alonso, Sandra Inés Revuelta, and Aurelio Fuertes Martín, “Intravenous ferric carboxymaltose-associated hypophosphatemia in patients with iron deficiency anemia. A common side effect,” Medicina Clínica (English Edition), 2016. View at Publisher · View at Google Scholar
  • Jacquelyn M. Powers, Mark Shamoun, Timothy L. McCavit, Leah Adix, and George R. Buchanan, “Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Who Respond Poorly to Oral Iron,” The Journal of Pediatrics, 2016. View at Publisher · View at Google Scholar
  • Maureen M. Okam, Todd A. Koch, and Minh-Ha Tran, “Iron supplementation, response in iron-deficiency anemia: analysis of five trials,” The American Journal of Medicine, 2017. View at Publisher · View at Google Scholar
  • Hale Akpinar, Satish Keshav, Mustafa Çetiner, Necati Örmeci, and Murat Törüner, “Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: Iron deficiency anemia working group consensus report,” Turkish Journal of Gastroenterology, vol. 28, no. 2, pp. 81–87, 2017. View at Publisher · View at Google Scholar
  • Palle Bager, Christian L. Hvas, and Jens F. Dahlerup, “Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions,” British Journal of Clinical Pharmacology, 2017. View at Publisher · View at Google Scholar
  • António Robalo Nunes, Ana Palricas Costa, Sara Lemos Rocha, and Ana Garcia de Oliveira, “Efficacy and Tolerability of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency at a Hospital Outpatient Clinic: A Retrospective Cohort Study of Real-World Clinical Practice,” Anemia, vol. 2017, pp. 1–7, 2017. View at Publisher · View at Google Scholar
  • Melvin H. Seid, Angelia D. Butcher, and Ashwin Chatwani, “Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia,” Anemia, vol. 2017, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  • Gary R. Lichtenstein, and Jane E. Onken, “Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron,” Digestive Diseases and Sciences, 2018. View at Publisher · View at Google Scholar
  • Nalini Sharma, Lalnunnem Jion Thiek, Roma Jethani, Dina Aisha Khan, and Jamil Mohammad, “Severe anaphylactic reaction with ferric carboxy maltose: A case report,” Journal of Clinical and Diagnostic Research, vol. 12, no. 5, pp. QD03–QD04, 2018. View at Publisher · View at Google Scholar
  • Lesley J. Scott, “Ferric Carboxymaltose: A Review in Iron Deficiency,” Drugs, 2018. View at Publisher · View at Google Scholar
  • N. Franklin Adkinson, William E. Strauss, Iain C. Macdougall, Kristine E. Bernard, Michael Auerbach, Robert F. Kaper, Glenn M. Chertow, and Julie S. Krop, “Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial,” American Journal of Hematology, 2018. View at Publisher · View at Google Scholar
  • Trond Espen Detlie, and Jørgen Jahnsen, “Editorial: awareness and prevention of intravenous iron-induced hypophosphataemia. Authors' reply,” Alimentary Pharmacology & Therapeutics, vol. 50, no. 5, pp. 610–611, 2019. View at Publisher · View at Google Scholar
  • Sara Gómez Rodríguez, José Carlos Castro Ramos, Cristina Abreu Padín, and Fernando Gómez Peralta, “Intravenous iron induced severe hypophosphatemia in a gastric bypass patient,” Endocrinología, Diabetes y Nutrición (English ed.), 2019. View at Publisher · View at Google Scholar
  • Sara Gómez Rodríguez, José Carlos Castro Ramos, Cristina Abreu Padín, and Fernando Gómez Peralta, “Hipofosfatemia severa por hierro intravenoso en paciente intervenida de bypass gástrico,” Endocrinología, Diabetes y Nutrición, 2019. View at Publisher · View at Google Scholar